Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against BlackRock TCP Capital Corp due to allegations of violations of federal securities laws, encouraging affected investors to discuss their legal options [2][4]. Group 1: Legal Investigation and Claims - The law firm is reminding investors of the April 6, 2026 deadline to seek the role of lead plaintiff in a federal securities class action against BlackRock TCP [2]. - The complaint alleges that BlackRock TCP and its executives made false or misleading statements regarding the valuation of investments and the quality of the portfolio, leading to understated unrealized losses and overstated net asset value (NAV) [4]. Group 2: Financial Performance and Market Reaction - On February 27, 2025, BlackRock TCP reported a significant weakening of its portfolio, with the number of portfolio companies on non-accrual status more than doubling, and debt investments on non-accrual status increasing by 289% from 3.7% to 14.4% of the portfolio [5]. - The company's NAV fell by 22.44% year over year to $9.23 per share, with total losses reaching $194.9 million, a 186% increase year over year, largely due to a $72.3 million net unrealized loss in the fourth quarter [5]. - Following the financial disclosures, BlackRock TCP's stock price dropped by $0.90, or 9.64%, to close at $8.44 per share on February 27, 2025 [5]. - On January 23, 2026, the company disclosed that its NAV per share was actually between $7.05 and $7.09, which was 19% lower than the previous quarter and 23.4% lower than the prior year [6]. - This announcement led to a further decline in stock price by $0.76, or 12.97%, closing at $5.10 per share on January 26, 2026 [6].

Core Viewpoint - Kyndryl Holdings, Inc. is under investigation for potential claims related to its cash management practices and internal controls, following significant disclosures that have led to a drastic decline in its stock price [4][5][6][7]. Group 1: Company Disclosures - On February 9, 2026, Kyndryl disclosed that its Audit Committee is reviewing cash management practices and related disclosures, prompted by voluntary document requests from the SEC's Division of Enforcement [5]. - Kyndryl expects to report material weaknesses in internal control over financial reporting for multiple reporting periods, indicating that previous assessments and auditor opinions should no longer be relied upon [6]. - The company announced the immediate departures of its Chief Financial Officer and General Counsel, and it will delay the filing of its Quarterly Report on Form 10-Q [7]. Group 2: Market Reaction - Following the disclosures regarding internal controls and management changes, Kyndryl's stock price declined approximately 50% on February 9, 2026 [7].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Ramaco Resources, Inc. due to allegations of misleading statements regarding the company's mining activities, particularly at the Brook Mine, which has led to a significant drop in stock price [2][4][5]. Group 1: Legal Investigation and Claims - Faruqi & Faruqi, LLP is encouraging investors who purchased Ramaco securities between July 31, 2025, and October 23, 2025, to discuss their legal rights, with a deadline of March 31, 2026, to seek the role of lead plaintiff in a federal securities class action [1][2]. - The complaint alleges that Ramaco and its executives violated federal securities laws by making false and misleading statements about the progress and activities at the Brook Mine [4]. - The investigation follows a report by Wolfpack Research, which claimed that the Brook Mine was not operational despite being presented as such, leading to a 9.6% drop in Ramaco's stock price on October 23, 2025 [5]. Group 2: Company Operations and Allegations - The allegations state that Ramaco had not commenced significant mining activities at the Brook Mine after its groundbreaking and that no active work was taking place, resulting in overstated development progress [4]. - Wolfpack Research's report described the Brook Mine as a "hoax" and indicated that no mining equipment was observed during multiple site visits, contradicting the company's public statements [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Ultragenyx Pharmaceutical Inc due to alleged violations of federal securities laws related to misleading statements about the efficacy of its drug setrusumab in treating Osteogenesis Imperfecta [2][4]. Group 1: Legal Investigation - The law firm is encouraging investors who suffered losses in Ultragenyx to contact them directly to discuss their legal options [1]. - There is a deadline of April 6, 2026, for investors to seek the role of lead plaintiff in a federal securities class action against Ultragenyx [2]. - The firm has a history of recovering hundreds of millions of dollars for investors since its founding in 1995 [3]. Group 2: Allegations Against Ultragenyx - The complaint alleges that Ultragenyx and its executives made false and misleading statements regarding the effects of setrusumab, creating a false impression of reliable information while downplaying risks associated with the Phase III Orbit study [4]. - Ultragenyx's optimism regarding the Phase III Orbit study's results was deemed misplaced, as the company failed to adequately disclose risks related to the study's design and results [4]. Group 3: Stock Performance Impact - On July 9, 2025, Ultragenyx announced that the Phase III Orbit study did not achieve statistical significance for its second interim analysis, leading to a stock price drop of over 25% [5]. - Following a December 29, 2025 announcement that both the Phase III Orbit and Cosmic studies failed to meet primary endpoints, Ultragenyx's stock fell more than 42% [6][7].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Paysafe Limited due to allegations of violations of federal securities laws, encouraging affected investors to contact them for legal options [2][4]. Group 1: Legal Investigation - The law firm is looking into claims against Paysafe Limited, with a deadline of April 7, 2026, for investors to seek the role of lead plaintiff in a federal securities class action [2]. - The firm has a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [3]. Group 2: Allegations Against Paysafe - The complaint alleges that Paysafe and its executives made false or misleading statements and failed to disclose significant risks, including exposure to a high-risk client and understated credit loss reserves [4]. - Specific issues cited include difficulties in banking services due to higher risk Merchant Category Codes, which could negatively impact revenue growth and financial guidance for fiscal year 2025 [4]. Group 3: Financial Performance - On November 13, 2025, Paysafe reported third-quarter financial results with revenue of $433.8 million, missing consensus estimates by $5.8 million, and a net loss of $87.7 million, a significant increase from a net loss of $12.98 million in the previous year [5]. - The company adjusted its full-year 2025 expected revenue to $17 million at the midpoint and adjusted EPS to $0.50 at the midpoint [5]. - The credit loss expense for the quarter was reported at $13,220, primarily due to expected chargebacks related to a specific merchant [6]. Group 4: Market Reaction - Following the financial report, Paysafe's stock price fell by $2.80, or 27.6%, closing at $7.36 per share on November 13, 2025, amid unusually heavy trading volume [6].

Core Viewpoint - A class action lawsuit has been certified for all Vaxart shareholders, including those who participated in a previous partial settlement, with a deadline for exclusion set for March 11, 2026 [1][2] Group 1: Class Action Details - The lawsuit is certified as a class action in the United States District Court for the Northern District of California, related to Vaxart, Inc. securities litigation [1][2] - The class includes individuals or entities that purchased or acquired Vaxart common stock or options between June 25 and July 24, 2020, and were damaged [1][2] - Members who purchased shares on June 26 or June 29, 2020, are part of a Subclass, which has specific criteria for participation [1] Group 2: Legal Representation and Options - Hagens Berman Sobol Shapiro LLP and Scott+Scott Attorneys at Law LLP are appointed as Class Counsel, representing the interests of the class members without requiring payment from them [1][2] - Class members have the option to either remain in the class, which binds them to court decisions, or request exclusion by the specified deadline, allowing them to pursue separate legal action [1][2] Group 3: Exclusion Process - To exclude from the class, individuals must submit a written request including personal details and proof of stock transactions by March 11, 2026 [1] - Excluded individuals will not be eligible for any recovery from the class action but can pursue their own claims against the Armistice Defendants [1][2]

Core Viewpoint - Wealthfront Corporation has experienced a significant decline in stock value following its first earnings release post-IPO, raising concerns among investors regarding its asset flow and strategic exposures in its mortgage business [3][4]. Group 1: Stock Performance - Wealthfront's stock was priced at $14.00 per share during its IPO on December 12, 2025, but has since fallen by $3.74, representing a 26.71% decrease, closing at $10.26 on January 14, 2026 [4]. Group 2: Investor Concerns - The decline in stock value is attributed to disappointing asset flow figures and a slowdown in client acquisitions, as indicated by softer net inflows in recent months [3]. - There is heightened scrutiny regarding the CEO's ownership stake in a banking partner that is crucial to Wealthfront's mortgage initiative, leading to speculation about potential conflicts of interest and long-term integration risks [3]. Group 3: Legal Investigation - Faruqi & Faruqi, LLP is investigating potential claims against Wealthfront Corporation, encouraging investors who have suffered significant losses to discuss their legal options [2].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ultragenyx To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Ultragenyx between August 3, 2023 and December 26, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Plug Power Inc. due to allegations of violations of federal securities laws, particularly concerning misleading statements about funding and project viability [4][6]. Group 1: Legal Investigation and Class Action - The firm is reminding investors of the April 3, 2026 deadline to seek the role of lead plaintiff in a federal securities class action against Plug Power [4]. - Investors who suffered losses in Plug Power between January 17, 2025, and November 13, 2025, are encouraged to contact the firm to discuss their legal rights [4][6]. Group 2: Allegations Against Plug Power - The complaint alleges that Plug Power and its executives made false statements regarding the availability of funds from the DOE Loan and the company's ability to construct necessary hydrogen production facilities [6]. - It is claimed that Plug Power was likely to pivot towards less ambitious projects, which was not disclosed to investors, leading to materially false public statements [6]. Group 3: Executive Changes and Market Reaction - On October 7, 2025, Plug Power announced the resignation of CEO Andrew Marsh and President Sanjay Shrestha, with the appointment of Jose Luis Crespo as their successor, which negatively impacted investor sentiment [7]. - Following the announcement of executive changes, Plug Power's stock price fell by $0.26 per share, or 6.29%, closing at $3.87 [8]. - On November 10, 2025, Plug Power reported a significant pivot in strategy, announcing the suspension of activities under the DOE loan program, which had not been previously disclosed [9][10]. Group 4: Financial Results and Further Declines - The company reported expectations of generating over $275 million in liquidity from a partnership with a major U.S. data center developer, which led to the suspension of DOE loan activities [9]. - Following the announcement of the suspension of plans to construct hydrogen facilities, Plug Power's stock price fell by $0.48 per share, or 17.58%, closing at $2.25 [11].

Core Viewpoint - Levi & Korsinsky has initiated an investigation into Ashford Hospitality Trust, Inc. for potential violations of federal securities laws [1] Group 1: Company Actions - Ashford Hospitality Trust announced the extension of its Highland mortgage loan secured by 18 hotels [2] - To maintain liquidity while evaluating strategic alternatives, Ashford has suspended preferred dividends for Series D, F, G, H, I, J, K, L, and M preferred stock, which were previously declared for record holders as of December 31, 2025, and due on January 15, 2026 [2] - Following the announcement of these actions, Ashford's stock price experienced a decline of over 8% on January 13, 2026 [2] Group 2: Legal and Investor Support - Investors who suffered losses on Ashford Hospitality Trust securities are encouraged to explore potential recovery options under federal securities laws [3] - Levi & Korsinsky is a well-established securities litigation firm with a strong track record in securing significant recoveries for shareholders [4]